Curebase
Latest round
- Series B
Last raised
- May 2022
Total raised
- $56M
Investors
- 9
About Curebase
Founded in 2017 and based in San Francisco, Curebase, Inc.Curebase, Inc. develops a comprehensive platform for clinical trials, enabling efficient data collection and management. The company was founded in 2017 by Tom Lemberg, who has a background in technology and entrepreneurship.Curebase specializes in providing a modern eClinical software platform designed for clinical trials, offering electronic Patient Reported Outcomes (ePRO), electronic Consent (eConsent), scheduling, notifications, and integrated Electronic Data Capture (EDC). Their offerings facilitate faster study launches, enhanced data quality, and improved patient engagement through intuitive form builders and seamless mobile access.Curebase's revenue model primarily revolves around subscription-based services for their eClinical platform. Clients engage in direct B2B transactions, with tailored pricing plans based on study size and complexity, including upfront fees for software deployment and ongoing subscription costs.In May 2022, Curebase, Inc. The company plans to introduce new product features aimed at improving user experience and efficiency.
Who invested in Curebase
9 investors across 2 rounds
See all investors in Curebase
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Curebase
Who invested in Curebase?
Curebase has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curebase raised?
Curebase has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Curebase last raise money?
Curebase's most recent round on record is a Series B, in May 2022.
What does Curebase do?
Founded in 2017 and based in San Francisco, Curebase, Inc.
Where is Curebase headquartered?
Curebase is headquartered in San Francisco, US.
Which VCs invest in companies like Curebase?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Curebase's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Curebase? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.